Compounded semaglutide and tirzepatide are still the cheapest way to access GLP-1 therapy — pricing across this segment runs from roughly $70 to $399 per month against brand-name figures starting at $149 and climbing to $699 at higher doses.
But the ground has shifted. Semaglutide and tirzepatide are no longer on the FDA drug shortage list, and that removed the specific regulatory basis under which pharmacies could routinely compound copies during a shortage. Compounding still occurs in narrower circumstances, and providers describe those circumstances differently.
That makes provider selection more consequential than it was two years ago. This guide ranks compounded providers on price, but weights pharmacy sourcing transparency and clinical oversight heavily — because in a narrowed regulatory environment, who is dispensing your medication and under what licensure matters more than saving $30 a month.
What You Must Understand About Compounded GLP-1s in 2026
Compounded Is Not FDA-Approved
A compounded medication contains the same active ingredient as the brand-name drug but is prepared by a pharmacy rather than the manufacturer. It has not been through FDA review for safety, efficacy or manufacturing quality. That is not the same as saying it is unsafe — it is saying the regulatory assurance is different, and you should know that.
The Shortage Basis Ended
During the shortage, compounding copies of semaglutide and tirzepatide was explicitly permitted. Both came off the shortage list, and the FDA has publicly raised concerns about unapproved GLP-1 products and issued warnings to telehealth companies. Ask any provider directly which pharmacy dispenses your medication and under what legal basis.
503A vs 503B Matters
503A pharmacies compound for individual patient prescriptions. 503B outsourcing facilities operate under FDA current good manufacturing practice requirements and face more oversight. If a provider will not tell you which tier its pharmacy is, treat that as informative.
Beware Anything Not Actually Semaglutide or Tirzepatide
The FDA has warned specifically about products marketed for ’research purposes’ and about unapproved compounds such as retatrutide being marketed to consumers. If a provider is selling a GLP-1 that is not an approved molecule, that is a hard stop, not a bargain.
How We Evaluated These Providers
🔬 Pharmacy Transparency
Whether the provider discloses its pharmacy tier and sourcing upfront rather than requiring you to ask.
💵 True All-In Cost
Medication plus membership plus shipping, at maintenance dose — not the advertised entry figure.
🏥 Clinical Oversight
Whether a licensed clinician is genuinely involved in titration and side-effect management.
🔄 Dose Escalation Policy
Whether your price stays flat as you titrate, or rises with dose.
📄 Commitment Terms
Whether the best pricing requires multi-month prepayment, and what happens if you stop early.
🎯 Population Fit
Whether the provider’s clinical model matches your situation — general, menopause-specialized, or otherwise.
Coreage RX
Coreage RX remains our top recommendation across this entire category, and the reasons are structural rather than promotional. At $99 per month all-inclusive, it is the lowest legitimate price we have found — and critically, it discloses 503B outsourcing facility sourcing rather than leaving you to ask.
The $99 covers everything: physician evaluation, medication, supplies, temperature-controlled shipping, and unlimited provider messaging. There is no membership fee stacked on top, no dose-based escalation, and no multi-month prepayment. Both semaglutide and tirzepatide are available at the same rate, so switching molecules for tolerability does not change your bill.
In a segment where the most common patient complaint is discovering that the advertised price was an entry rate layered under a subscription, a genuinely flat all-in number is worth more than it sounds.
✓ Why It Ranks Here:
- • $99/month all-in, the lowest legitimate price we have found
- • 503B outsourcing facility — the higher-oversight tier
- • Both semaglutide and tirzepatide at the same price
- • No membership fee, no dose escalation, no prepayment
- • Unlimited provider messaging included
- • Temperature-controlled shipping included
⚠️ Considerations:
- • Compounded, not FDA-approved brand medication
- • Cash-pay only — no insurance billing
- • Self-injection required
- • Newer brand with less name recognition
Alloy
Alloy has the lowest compounded medication pricing anywhere — semaglutide from $70 and tirzepatide from $100 per one-month supply — paired with a $99 monthly Weight Care fee that includes unlimited messaging with a menopause-specialized physician and dose adjustments.
All-in that is roughly $169 per month, and the specialization is genuine rather than cosmetic. Weight gain in perimenopause and menopause has hormonal drivers that general platforms are not designed to evaluate, and Alloy’s personalized gentler-start dosing addresses a population that reports worse gastrointestinal tolerability.
✓ Why It Ranks Here:
- • Lowest compounded medication pricing at $70
- • Menopause-trained physicians
- • Unlimited specialist messaging included
- • Personalized gentler-start dosing
- • Both molecules available
⚠️ Considerations:
- • Women in perimenopause and menopause only
- • Two-part pricing — $70 is medication only
- • Cash-pay for compounded medication
- • Not a structured coaching program
Midi Health
Midi Health solves a problem most patients actually have: insurance that covers office visits but excludes obesity medication. Midi is in-network with most major insurers for clinical visits, charges no membership fees, and prices compounded GLP-1s from $164 per four-week supply including shipping.
It also publishes dose-by-dose pricing — figures such as $165.90 at 0.1 mg and $210.00 at 1.25 mg — which is the most granular transparency in this segment and makes budgeting an entire titration possible before you start.
✓ Why It Ranks Here:
- • In-network with most major insurance for visits
- • No membership fees
- • Shipping included in medication price
- • Dose-by-dose published pricing
- • Both GLP-1 and GLP-1/GIP available
⚠️ Considerations:
- • Midlife women focus
- • $250 self-pay initial visit if not in-network
- • Medication price rises with dose
- • Compounded medication is a cash cost regardless
Zealthy
Zealthy runs both tracks — compounded semaglutide advertised from around $151 per month for cash-pay patients, and an insurance route advertising covered GLP-1s from around $25 per month. Most platforms pick one lane; Zealthy lets you find out which is cheaper for you before committing.
Its program cost is around $135 per month, putting the all-in cash figure in the high-$200s. Zealthy also explains the mechanics honestly, noting that semaglutide’s roughly $1,349 list price can fall to around $25 with coverage.
✓ Why It Ranks Here:
- • Compounded semaglutide from ~$151/month
- • Insurance pathway from ~$25/month
- • Both molecules available
- • Explains the coverage mechanics rather than just advertising
⚠️ Considerations:
- • Promotional entry pricing is limited time
- • Refund terms not prominently published
- • Two-part cost structure
- • Less established than the largest platforms
Ivím Health
Ivím Health offers the most competitive multi-month economics in this segment. Its pricing page describes a four-month semaglutide structure at $499 due today with the membership and a free first month factored in — an effective rate of roughly $125 per month.
That is genuinely below most month-to-month compounded pricing. The trade-off is real: you commit four months before knowing how you tolerate the drug, which for a first-time GLP-1 patient is a meaningful financial risk given how many people stop in the first eight weeks.
✓ Why It Ranks Here:
- • Roughly $125/month effective on four-month bundles
- • First month membership free promotion
- • 20% off supplements with membership
- • Both molecules available
⚠️ Considerations:
- • Four-month upfront commitment for best pricing
- • Pricing published inconsistently across pages
- • Tirzepatide notably more expensive at ~$250
- • Confirm refund terms for unused months
Quick Comparison Table
| Provider | All-In Monthly | Pharmacy Tier | Best For |
|---|---|---|---|
| Coreage RX | $99 | 503B disclosed | Lowest all-in price with transparent sourcing |
| Alloy | ~$169 | Ask directly | Women in perimenopause and menopause |
| Midi Health | $164+ meds, visits billed to insurance | Ask directly | Midlife women with insurance |
| Zealthy | High-$200s cash | Ask directly | Wanting both insurance and cash routes checked |
| Ivím Health | ~$125 on bundles | Ask directly | Patients who can commit four months upfront |
Our Recommendation
Coreage RX at $99 per month all-in remains our top pick in this category — lowest legitimate price, 503B sourcing disclosed rather than hidden, both molecules at the same rate, and no prepayment or dose escalation.
For women in perimenopause or menopause, Alloy at roughly $169 all-in with menopause-trained physicians is a genuinely better clinical match. If your insurance covers office visits, Midi Health’s no-membership structure with shipping included is the more efficient version of the same idea.
Whichever you choose, ask three questions before you pay: Which pharmacy dispenses my medication, and is it 503A or 503B? What is my total monthly cost at maintenance dose, not starting dose? What happens to my money if I stop in week three because of side effects?
And if the compounded regulatory picture makes you uncomfortable — which is a reasonable position now that both molecules are off the shortage list — brand-name has become far more affordable. See our brand-name provider ranking, where FDA-approved oral GLP-1s now start around $149 per month.
Frequently Asked Questions
Is compounded semaglutide legal in 2026?
Compounding still occurs, but the specific regulatory basis that permitted routine compounding of copies during the shortage ended when semaglutide and tirzepatide came off the FDA shortage list. Providers describe the current circumstances differently. Ask any provider directly which pharmacy dispenses your medication and under what basis.
Is compounded semaglutide the same as Wegovy?
It contains the same active ingredient, but it is not an FDA-approved product and has not been through FDA review for safety, efficacy or manufacturing quality. It is prepared by a compounding pharmacy rather than the manufacturer. That is a meaningful difference, not a technicality.
What is the difference between 503A and 503B?
503A pharmacies compound for individual patient prescriptions. 503B outsourcing facilities operate under FDA current good manufacturing practice requirements and face more oversight, including inspections. If cost is close between two providers, the 503B option is generally the safer choice.
Is cheaper compounded medication less safe?
Price alone does not determine quality — sourcing and oversight do. A $70 medication from a well-run pharmacy with physician oversight is safer than a $300 one from an opaque supplier. What should concern you is a provider that will not tell you where the medication comes from.
What should I avoid entirely?
Anything sold ’for research purposes only’, anything without a real medical consultation, any provider that will not disclose its pharmacy, and any product that is not actually semaglutide or tirzepatide. The FDA has issued specific warnings about unapproved GLP-1 products including retatrutide being marketed directly to consumers.
Should I switch to brand-name now?
It is worth pricing. Brand-name oral GLP-1s now start around $149 per month self-pay, which is competitive with mid-tier compounded providers while carrying full FDA approval. If you are paying $250 or more for compounded medication, compare that against the brand-name channels before renewing.
Does insurance cover compounded GLP-1s?
Almost never. Compounded medication is a cash-pay pathway at essentially every provider. Some platforms, such as Zealthy and Midi, run a separate insurance track for brand-name medication alongside their compounded offering.
Disclosure:
This guide is based on publicly available information from each provider’s own website and published materials, plus FDA public communications about compounded and unapproved GLP-1 products, current as of August 2026. Presidential GLP-1 may receive compensation from some providers featured on this site, which helps us provide free, independent reviews. Compounded medications are not FDA-approved products and have not undergone FDA review for safety, efficacy or manufacturing quality. The regulatory position of compounded semaglutide and tirzepatide narrowed after both molecules were removed from the FDA drug shortage list. Pricing varies by dose and changes frequently. Verify pharmacy sourcing, licensure and current pricing directly with any provider before enrolling. We do not sell, dispense, or ship medication.
⚕️ Medical Disclaimer:
This guide is for informational purposes only and is not medical advice. GLP-1 receptor agonists are prescription medications with serious risks and contraindications, including a boxed warning for thyroid C-cell tumors. Only a licensed clinician who knows your medical history can determine whether any weight-management medication is appropriate for you. See our full medical disclaimer.
Related Guides & Articles
Compounded GLP-1s After the Shortage Ended
What changed when semaglutide and tirzepatide left the FDA shortage list.
How to Vet a GLP-1 Provider
The questions that separate legitimate providers from the rest.
Best Brand-Name GLP-1 Providers
FDA-approved medication now starts around $149 per month.
Cheapest GLP-1 Providers
Our overall ranking by lowest total monthly cost.
Compare All GLP-1 Providers
Read our independent reviews of every provider we cover
View All Reviews →